Skip to main content
. 2021 Mar 25;51(6):504–514. doi: 10.4070/kcj.2020.0448

Table 3. Operative profile.

Characteristics Overall (n=269) PVE (n=56) NVE (n=213) p value
Emergent surgery 81 (30.1) 20 (35.7) 61 (28.6) 0.388
Preoperative MCS 2 (0.7) - 2 (0.9) 1.000
Primary procedure
Valve replacement 205 (76.2) 56 (100.0) 149 (70.0) <0.001
AVR 90 (33.5) 26 (46.4) 64 (30.0)
MVR 78 (29.0) 19 (33.9) 59 (27.7)
TVR 4 (1.5) 2 (3.6) 2 (0.9)
PVR 3 (1.1) - 3 (1.4)
Double valve replacement 29 (10.8) 8 (16.1) 21 (9.9)
Triple valve replacement 1 (0.4) 1 (1.8) -
Valve repair 55 (20.4) - 55 (25.8) <0.001
MVP 52 (19.3) - 52 (24.4)
TVP 2 (0.7) - 2 (0.9)
Double valve repair 1 (0.4) - 1 (0.5)
Valve replacement + repair 6 (2.2) - 6 (2.8) 0.446
Vegetation removal 3 (1.1) - 3 (1.4) 0.859
Valve substitute
Bioprosthetic valve replacement 88 (32.7) 23 (41.1) 65 (30.5) 0.181
Mechanical valve replacement 123 (45.7) 33 (58.9) 90 (42.3) 0.038
MAIVF repair 37 (13.8) 26 (46.4) 11 (5.2) <0.001
Concomitant cardiac procedure
CABG 8 (3.0) 2 (3.6) 6 (2.8) 1.000
Valve surgery 39 (14.5) 9 (16.1) 30 (9.4) 0.233
Surgical ablation of AF 23 (8.6) 4 (7.1) 19 (8.9) 0.877
Minimally invasive approach
Upper sternotomy 14 (5.2) 3 (5.4) 11 (5.2) 1.000
Thoracotomy 67 (24.9) 3 (5.4) 64 (30) <0.001
Cardiopulmonary bypass time (minutes) - 235.1±105.3 133.3±51.0 <0.001
Aortic cross clamping time (minutes) - 145.2±66.6 92.9±14.4 <0.001

Values are number (%) or mean±standard deviation, unless otherwise indicated.

AF = atrial fibrillation; AVR = aortic valve replacement; CABG = coronary artery bypass graft; MAIVF = mitral aortic intervalvular fibrosa; MCS = mechanical circulatory support; MVP = mitral valve prolapse; MVR = mitral valve replacement; PVR = pulmonary valve replacement; TVP = tricuspid valve prolapse; TVR = tricuspid valve replacement.